← Leaderboards
Esteban M Lucero
University Of Colorado Denver
$433,675
Attributed
$433,675
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $99.4K · FY2019–25$100K$75K$50K$25K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$433,675 · 2
By mechanism
K00$360,786 · 1
F99$72,889 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ingrid A Binswanger$5,265,673
- Judith Baxter$778,413
- Dana Dabelea$57,991,262
- Tessa L Crume$2,036,814
- Diego Restrepo$26,457,289
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposConditioned FearBiochemicalAgedAtp PhosphohydrolaseAbeta OligomerAmyloidAffectAnimalsArchitectureClinically SignificantAwardAmericanBehavioralAcuteBiological ModelsBrainBrain InitiativeCareerCaregiversCell Culture TechniquesCell PhysiologyCognitiveDefect
Grant awards (7)
Understanding the role of genetic admixture on Alzheimerâs Disease risk in LatÃno Populations$99,364
K00 · FY2025 · AG · contact PI
Understanding the role of genetic admixture on Alzheimerâs Disease risk in LatÃno Populations$94,942
K00 · FY2024 · AG · contact PI
Understanding the role of genetic admixture on Alzheimerâs Disease risk in LatÃno Populations$83,240
K00 · FY2023 · AG · contact PI
Understanding the role of genetic admixture on Alzheimerâs Disease risk in LatÃno Populations$83,240
K00 · FY2022 · AG · contact PI
Targeting Kinesin-5 Activity for treatment of Alzheimer's disease$15,018
F99 · FY2021 · NS · contact PI
Targeting Kinesin-5 Activity for treatment of Alzheimer's disease$18,400
F99 · FY2020 · NS · contact PI
Targeting Kinesin-5 Activity for treatment of Alzheimer's disease$39,471
F99 · FY2019 · NS · contact PI